Latest News of VRCA
Verrica Pharmaceuticals Inc. (VRCA): Worst 52-Week Low Stock to Buy Now
The recent interest rate cut by the U.S. Federal Reserve has boosted investor sentiment and market outlook. With stocks rallying, the focus shifts to stocks at 52-week lows, presenting potential buyin...
When Will Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Turn A Profit?
Verrica Pharmaceuticals Inc., a clinical-stage dermatology therapeutics company, is expected to break even by 2026. Analysts project a profit of US$2.0m after a final loss in 2025....
Recent 12% pullback would hurt Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) insiders
Individual insiders hold the largest stake in Verrica Pharmaceuticals, followed by institutional investors and hedge funds. Top shareholders have the power to influence company decisions. Insider owne...